A paper in today's Science offers a candidate pathway for inflammatory processes in Alzheimer's disease; the pathway uses the CD40 receptor on microglia and is upregulated by Aβ. Michael Mullan, Jun Tan, and colleagues at the University of South Florida followed up two leads-evidence that microglia may be involved in inflammatory Alzheimer's processes and that the CD40 receptor on microglia mediates inflammatory intracellular signaling-and asked whether these were related.
Working in cultured microglial cells, they found that both Aβ[1-40] and Aβ[1-42], either added exogenously or already present in microglia from transgenic mice, markedly increased expression of the CD40 receptor. When the Aβ-stimulated microglia were treated with a CD40 ligand, significantly more cultured neurons died and production of tumor necrosis factor α (TNF-α) increased to concentrations known to cause cell injury. Blockade of TNF-α eliminated this cell death.
The authors then carried their experiments into an in vivo model. They crossed a mouse line that features significant Aβ deposition (Tg APP[SW]) with mice deficient in CD40 ligand and found a reduction in TNF-α production in cultured microglia from these animals. Finally, the authors showed that crossing Tg APP[SW] mice with those deficient in CD40 ligand resulted in a reduction in the early abnormal tau phosphorylation seen in TG APP[SW] mice.
The authors take this evidence to suggest that the CD40-CD40 ligand interaction--primed by Aβ-and a resulting microglial-mediated inflammatory process-occurs early in Alzheimer's pathogenesis. This raises the possibility that therapeutic approaches to blocking the CD40 signaling pathway might suppress neurodegeneration in Alzheimer's.—Hakon Heimer
No Available References
No Available Further Reading
- Tan J, Town T, Paris D, Mori T, Suo Z, Crawford F, Mattson MP, Flavell RA, Mullan M. Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. Science. 1999 Dec 17;286(5448):2352-5. PubMed.